Evaluation of bronchial inflammatory response via expression of NF-κB & IL-1β in mice airways by TAK-242 and LPS administration: Targeting TLR4/MD2 signalling pathway
Keywords:
bronchial asthma, lipopolysaccharide, nuclear factor kappa B, ovalbumin, TAK-242, toll-like receptorAbstract
Optimization of animal model of asthma via toll like receptors-4 (TLR4) activation for bacterial exacerbation of asthma. LPS contributes to asthma exacerbations. Ovalbumin protein sensitization & challenge were examined after LPS exposure. Present research aimed, TLR4 stimulation mediated TLR4/MD2 complex formation is inhibited by TAK-242, a newer compound, for bacterial asthma management in a mouse model. Swiss Albino mice were induced with OVA (10µg, i.p. and 50 µg, i.n.) and LPS (20 µg, i.p. and 4 µg, i.n.), stimulates TLR4 receptor mediated TLR4-MD2 complex formation in toxic groups. Animals were sensitized (i.p.) on 0, 7th and 14th day and challenged (i.n.) followed by TAK-242 treatment (0.1 mg/kg, 1 mg/kg &10 mg/kg i.p.) given on 21st and 22nd days, followed by euthanasia and samples; BALF and lung tissue were collected on 23rd day. Further analysis such as total leukocyte count & differential leukocyte cell count, lung histopathology & immunohistochemistry of NF-κB, proteins like Interleukin-1β in BALF and lungs in toxic, treatment groups in comparison with control group were carried out. TAK-242 reduced TLC/DLC values in BALF, including eosinophil, neutrophil, lymphocyte, macrophage counts, lung histological alterations and immunohistochemical positivity of NF-κB and IL-1β proteins expression.
Downloads
References
Fleming L. Asthma exacerbation prediction: Recent insights. Curr Opin Allergy Clin Immunol. 2018;18(2):117-123. doi:10.1097/ACI.0000000000000428
Denlinger LC, Phillips BR, Ramratnam S, et al. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations. Am J Respir Crit Care Med. 2017;195(3):302-313. doi:10.1164/RCCM.2016020419OC/SUPPL_ FILE/DISCLOSURES.PDF
Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015;3(11):849-858. doi:10.1016/S2213-2600(15)00367-7
De Nardo D. Toll-like receptors: Activation, signalling and transcriptional modulation. Cytokine. 2015;74(2):181-189. doi:10.1016/J.CYTO.2015.02.025
Ding F, Fu Z, Liu B. Lipopolysaccharide exposure alleviates asthma in mice by regulating Th1/Th2 and treg/Th17 balance. Med Sci Monit. 2018;24:3220-3229. doi:10.12659/MSM.905202
Qian G, Jiang W, Zou B, et al. LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma. J Exp Med. 2018;215(9):2397-2412. doi:10.1084/jem.20172225
Zielen S, Trischler J, Schubert R. Lipopolysaccharide challenge: Immunological effects and safety in humans. Expert Rev Clin Immunol. 2015;11(3):409-418. doi:10.1586/1744666X.2015.1012158
Athari SS, Athari SM, Beyzay F, Movassaghi M, Mortaz E, Taghavi M. Critical role of Toll-like receptors in pathophysiology of allergic asthma. Eur J Pharmacol. 2017;808(January):21-27. doi:10.1016/j.ejphar.2016.11.047
Starkhammar M, Larsson O, Kumlien Georén S, et al. Toll-like receptor ligands LPS and poly (I:C) exacerbate airway hyperresponsiveness in a model of airway allergy in mice, independently of inflammation. PLoS One. 2014;9(8). doi:10.1371/ journal.pone.0104114
Maltby S, Tay HL, Yang M, Foster PS. Mouse models of severe asthma: Understanding the mechanisms of steroid resistance, tissue remodelling and disease exacerbation. Respirology. 2017;22(5):874-885. doi:10.1111/RESP.13052
Mishra V, Banga J, Silveyra P. Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets. Pharmacol Ther. 2018;181:169-182. doi:10.1016/J.PHARMTHERA.2017.08.011
Lv H, Liu P, Zhou F, Gao Z, Fan W, Xu Y. TAK-242 ameliorates olfactory dysfunction in a mouse model of allergic rhinitis by inhibiting neuroinflammation in the olfactory bulb. Int Immunopharmacol. 2021;92(December 2020):1-9. doi:10.1016/j.intimp.2021.107368
Wang D, Tao K, Xion J, et al. TAK-242 attenuates acute cigarette smoke-induced pulmonary inflammation in mouse via the TLR4/NF-κB signaling pathway. Biochem Biophys Res Commun. 2016;472(3):508-515. doi:10.1016/j.bbrc.2016.03.001
Szczȩsny G, Veihelmann A, Massberg S, Nolte D, Messmer K. Long-term anaesthesia using inhalatory isoflurane in different strains of mice - The haemodynamic effects. Lab Anim. 2004;38(1):64-69. doi:10.1258/00236770460734416
Starkhammar M, Georén SK, Dahlén SE, Cardell LO, Adner M. TNFα-blockade stabilizes local airway hyperresponsiveness during TLR-induced exacerbations in murine model of asthma. Respir Res. 2015;16(1):1-9. doi:10.1186/s12931-015-0292-5
Luo W, Han Y, Meng P, et al. Resatorvid relieves breast cancer complicated with depression by inactivating hippocampal microglia through tlr4/nf-κb/nlrp3 signaling pathway. Cancer Manag Res. 2020;12:13003-13014. doi:10.2147/CMAR.S279800
Blyth DI, Pedrick MS, Savage TJ, Bright H, Beesley JE, Sanjar S. Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: Effect of concurrent infection with respiratory syncytial virus and response to dexamethasone. Am J Respir Cell Mol Biol. 1998;19(1):38-54. doi:10.1165/ ajrcmb.19.1.2930
Thakur VR, Khuman V, Beladiya J V., Chaudagar KK, Mehta AA. An experimental model of asthma in rats using ovalbumin and lipopolysaccharide allergens. Heliyon. 2019;5(11). doi:10.1016/j.heliyon.2019.e02864
Atkinson C, He S, Morris K, et al. Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation. J Immunol. 2010;185(11):7007-7013. doi:10.4049/JIMMUNOL.1001504
Okura Y, Dec GW, Hare JM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003;41(2):322-329. doi:10.1016/S0735-1097(02)02715-8
Kim DI, Song MK, Lee K. Comparison of asthma phenotypes in OVA-induced mice challenged via inhaled and intranasal routes. BMC Pulm Med. 2019;19(1):1-11. doi:10.1186/s12890-019-1001-9
Nguyen D, Nguyen D. Quantifying chromogen intensity in immunohistochemistry via reciprocal intensity. Protoc Exch. Published online December 20, 2013. doi:10.1038/protex.2013.097
Martin JG, Tamaoka M. Rat models of asthma and chronic obstructive lung disease. Pulm Pharmacol Ther. 2006;19(6):377-385. doi:10.1016/J.PUPT.2005.10.005
Upur H, Abdureyim S, Amat N, Umar A, Berke B, Moore N. Anti-inflammatory, immunomodulatory, and heme oxygenase-1 inhibitory activities of Ravan Napas, a formulation of Uighur traditional medicine, in a rat model of allergic asthma. Evidence-based Complement Altern Med. 2011;2011. doi:10.1155/2011/725926
Schröder NWJ, Maurer M. The role of innate immunity in asthma: Leads and lessons from mouse models. Allergy Eur J Allergy Clin Immunol. 2007;62(6):579-590. doi:10.1111/j.1398-9995.2007.01386.x
Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145-151. doi:10.1016/j.cyto.2008.01.006
Liew FY, Xu D, Brint EK, O’Neill LAJ. Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005 56. 2005;5(6):446-458. doi:10.1038/nri1630
Ren Y, Ichinose T, He M, Youshida S, Nishikawa M, Sun G. Co-exposure to lipopolysaccharide and desert dust causes exacerbation of ovalbumin-induced allergic lung inflammation in mice via TLR4/MyD88-dependent and -independent pathways. Allergy, Asthma Clin Immunol. 2019;15(1):1-12. doi:10.1186/s13223-019-0396-4
Arvidsson MB, Löwhagen O, Rak S. Early and late phase asthmatic response in lower airways of cat-allergic asthmatic patients – a comparison between experimental and environmental allergen challenge. Allergy. 2007;62(5):488-494. doi:10.1111/J.1398-9995.2007.01278.X
El-Naa MM, El-Refaei MF, Nasif WA, Abduljawad SH, El-Brairy AI, El-Readi MZ. In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists in animal model of bronchial asthma. J Pharm Pharmacol. 2015;67(10):1421-1430. doi:10.1111/JPHP.12445
Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma. Front Microbiol. 2013;4(SEP):263. doi:10.3389/fmicb.2013.00263
Alharbi KS, Fuloria NK, Fuloria S, et al. Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact. 2021;345:109568. doi:10.1016/j.cbi.2021.109568
Kumar, S. (2022). A quest for sustainium (sustainability Premium): review of sustainable bonds. Academy of Accounting and Financial Studies Journal, Vol. 26, no.2, pp. 1-18
Allugunti, V.R. (2019). Diabetes Kaggle Dataset Adequacy Scrutiny using Factor Exploration and Correlation. International Journal of Recent Technology and Engineering, Volume-8, Issue-1S4, pp 1105-1110.
Viswanatha KKRC, Reddy A, Elango N M (2019). Diabetes Kaggle Dataset Adequacy Scrutiny using Factor Exploration and Correlation, International Journal of Recent Technology and Engineering (IJRTE) Vol. 8.
Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ. Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids. J Immunol. 1992;149(9):3078-3082. Accessed January 17, 2022. http://www.ncbi.nlm.nih.gov/pubmed/1401932
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
